Moneycontrol PRO

you are here: HomeNewsBusinessMarketsUSFDA settlement to hit Ranbaxy by Rs 60/sh: Espirito Santo

SHOW NAMES

Trending Topics

business

USFDA settlement to hit Ranbaxy by Rs 60/sh: Espirito Santo

Ranbaxy Laboratories said it has reached a settlement with the US Food and Drug Administration while setting aside USD 500 million to address its potential liability from a separate US Justice Department investigation.

first published: Dec 21, 2011 09:31 am

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347